-
‣About TrovaGene
TrovaGene is a molecular diagnostics company with a focus on facilitating and enhancing personalized medicine.
Our goal is to leverage our platform to enhance the likelihood that the right patient gets the right treatment at the right time.
Our primary platform and area of expertise involves the development of urine-based (i.e. transrenal) nucleic acid tests using proprietary methods of DNA (Tr-DNA) and RNA (Tr-RNA) preparation and detection.
TrovaGene, Inc. (TROV.PK), a publicly traded company based in San Diego, Calif., is dedicated to the development and commercialization of urine-based (i.e.transrenal) molecular in-vitro diagnostic products. TrovaGene (from the Italian root word meaning “to find”) is initially targeting medical conditions in which the standard of care requires samples that are difficult, painful, invasive or dangerous to obtain and analyze as well as conditions for which no diagnostic tests currently exist. These targets include tests for the rapid and convenient screening for, detection and monitoring of infectious diseases, cancer, prenatal genetic testing, and the monitoring of organ/cell transplants.
The company’s founding scientists were the first to report that cell free fragments of DNA from normal cell death that circulate in the blood can cross the kidney barrier and be detected in urine. The company believes that this transrenal technology will open significant new markets in the molecular diagnostics field and lead to improvements in the area of personalized medicine.
TrovaGene has a dominant patent position as it relates to transrenal molecular testing. We have issued U.S. and European patents that cover any and all testing for nucleic acid targets that pass through the kidney. In addition to these core patents we have numerous patent applications pending in the areas of cancer, infectious diseases, transplantation, prenatal and genetic testing. This patent position rivals the importance of the Roche PCR and Gen-Probe ribosomal RNA patents in the molecular diagnostic field.
TROV.PK
TROVAGENE INC (TROV.PK)
